You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 107 No. 4, April 1973 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Verrucae Vulgaris Rejection

A Preliminary Study of Contact Dermatitis and Cellular Immunity Response

MAJ Joseph H. Greenberg, MC; MAJ T. Larry Smith, MC; Roger M. Katz, MD

Arch Dermatol. 1973;107(4):580-582.


Abstract



Clinical and histologic correlations were performed on five adult patients with verrucae vulgaris lesions and on four normal adult volunteers without verrucae after induction of irritant contact dermatitis and subsequent allergic contact immune response to 1-nitro-2,4-dichlorobenzene (DNCB). Four of the five patients with warts and all of the control patients developed normal delayed cutaneous hypersensitivity (DCH) reactions. The four patients with verrucae vulgaris, with induced DCH responses, had disappearance of the warts after topical challenge by DNCB. After several weeks, two of these patients experienced complete disappearance of all nontreated warts, as well.



Author Affiliations



USA; USA; Fort Sam Houston, Tex

From the Department of Dermatology (Drs. Greenberg and Smith), and the Allergy-Immunology Service (Dr. Katz), Brooke General Hospital, Fort Sam Houston, Tex. Dr. Katz is now at UCLA School of Medicine, Los Angeles.


Footnotes



Accepted for publication Nov 21, 1972.

Reprint requests to Department of Pediatrics, Division of Allergy and Immunology, UCLA School of Medicine, Los Angeles 90024 (Dr. Katz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Mutagenicity of Dinitrochlorobenzene
Black et al.
Arch Dermatol 1985;121:348-349.
ABSTRACT  

Recovery Processes During Regression of Plane Warts
Takigawa et al.
Arch Dermatol 1977;113:1214-1218.
ABSTRACT  

2,4-Dinitrochlorobenzene Therapy for Plantar Warts
Greenberg
Arch Dermatol 1974;109:910-910.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.